These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33087092)

  • 1. Diagnostic test accuracy of point-of-care procalcitonin to diagnose serious bacterial infections in children.
    Waterfield T; Maney JA; Lyttle MD; McKenna JP; Roland D; Corr M; Patenall B; Shields MD; Woolfall K; Fairley D;
    BMC Pediatr; 2020 Oct; 20(1):487. PubMed ID: 33087092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study.
    Nijman RG; Moll HA; Smit FJ; Gervaix A; Weerkamp F; Vergouwe Y; de Rijke YB; Oostenbrink R
    Pediatr Infect Dis J; 2014 Nov; 33(11):e273-9. PubMed ID: 25093971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection.
    Carrol ED; Mankhambo LA; Jeffers G; Parker D; Guiver M; Newland P; Banda DL; ; Molyneux EM; Heyderman RS; Molyneux ME; Hart CA
    PLoS One; 2009 Aug; 4(8):e6621. PubMed ID: 19675669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin, C-reactive protein, neutrophil gelatinase-associated lipocalin, resistin and the APTT waveform for the early diagnosis of serious bacterial infection and prediction of outcome in critically ill children.
    Nielsen MJ; Baines P; Jennings R; Siner S; Kolamunnage-Dona R; Newland P; Peak M; Chesters C; Jeffers G; Downey C; Broughton C; McColl L; Preston J; McKeever A; Paulus S; Cunliffe N; Carrol ED
    PLoS One; 2021; 16(2):e0246027. PubMed ID: 33544738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.
    Milcent K; Faesch S; Gras-Le Guen C; Dubos F; Poulalhon C; Badier I; Marc E; Laguille C; de Pontual L; Mosca A; Nissack G; Biscardi S; Le Hors H; Louillet F; Dumitrescu AM; Babe P; Vauloup-Fellous C; Bouyer J; Gajdos V
    JAMA Pediatr; 2016 Jan; 170(1):62-9. PubMed ID: 26595253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is procalcitonin useful in early diagnosis of serious bacterial infections in children?
    Thayyil S; Shenoy M; Hamaluba M; Gupta A; Frater J; Verber IG
    Acta Paediatr; 2005 Feb; 94(2):155-8. PubMed ID: 15981747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study.
    Park JS; Byun YH; Lee JY; Lee JS; Ryu JM; Choi SJ
    BMC Pediatr; 2021 Mar; 21(1):109. PubMed ID: 33663442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viremia as a predictor of absence of serious bacterial infection in children with fever without source.
    Galetto-Lacour A; Cordey S; Papis S; Mardegan C; Luterbacher F; Combescure C; Lacroix L; Gervaix A; Kaiser L; Posfay-Barbe KM; L'Huillier AG
    Eur J Pediatr; 2023 Feb; 182(2):941-947. PubMed ID: 36399200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department.
    Andreola B; Bressan S; Callegaro S; Liverani A; Plebani M; Da Dalt L
    Pediatr Infect Dis J; 2007 Aug; 26(8):672-7. PubMed ID: 17848876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis.
    Alejandre C; Guitart C; Balaguer M; Torrús I; Bobillo-Perez S; Cambra FJ; Jordan I
    Eur J Pediatr; 2021 Mar; 180(3):833-842. PubMed ID: 32929531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center.
    Galetto-Lacour A; Zamora SA; Gervaix A
    Pediatrics; 2003 Nov; 112(5):1054-60. PubMed ID: 14595045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin.
    Olaciregui I; Hernández U; Muñoz JA; Emparanza JI; Landa JJ
    Arch Dis Child; 2009 Jul; 94(7):501-5. PubMed ID: 19158133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza.
    Li Z; He L; Li S; He W; Zha C; Ou W; Hou Q; Wang W; Sun X; Liang H
    Influenza Other Respir Viruses; 2019 Mar; 13(2):184-190. PubMed ID: 30443990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.
    Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J;
    Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic test accuracy of procalcitonin and C-reactive protein for predicting invasive and serious bacterial infections in young febrile infants: a systematic review and meta-analysis.
    Norman-Bruce H; Umana E; Mills C; Mitchell H; McFetridge L; McCleary D; Waterfield T
    Lancet Child Adolesc Health; 2024 May; 8(5):358-368. PubMed ID: 38499017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for the diagnostic performance of C reactive protein, procalcitonin and interleukin-6 for serious bacterial infections among children ≤36 months old presenting with fever without source: a systematic review and meta-analysis.
    Sutiman N; Yao SHW; Goh SSM; Sultana R; Chong SL
    BMJ Paediatr Open; 2024 Mar; 8(1):. PubMed ID: 38499348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Petechiae in children" (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA - a study protocol.
    Waterfield T; Lyttle MD; Fairley D; Mckenna J; Woolfall K; Lynn F; Maney JA; Roland D; Weir A; Shields MD;
    BMC Pediatr; 2018 Jul; 18(1):246. PubMed ID: 30060751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs.
    Lacour AG; Gervaix A; Zamora SA; Vadas L; Lombard PR; Dayer JM; Suter S
    Eur J Pediatr; 2001 Feb; 160(2):95-100. PubMed ID: 11271398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study.
    van der Does Y; Rood PPM; Ramakers C; Schuit SCE; Patka P; van Gorp ECM; Limper M
    Clin Microbiol Infect; 2018 Dec; 24(12):1297-1304. PubMed ID: 30268671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin to Detect Bacterial Infections in Critically Ill Pediatric Patients.
    Jacobs DM; Holsen M; Chen S; Fusco NM; Hassinger AB
    Clin Pediatr (Phila); 2017 Aug; 56(9):821-827. PubMed ID: 28720036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.